News

A recent study led by Paul DeCaen, Ph.D., associate professor of Pharmacology, has identified novel molecular mechanisms by ...
Tamarr, who turns 20 years old on Aug. 25, will be monitored by veterinarians without anesthesia and may begin to spend less ...
Free Malaysia Today on MSN5h
Why CKD continues to fly under the radar
The slow, symptomless nature of chronic kidney disease and lack of public awareness often lead to late diagnosis.
Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic ...
The goal with ProKidney Corp.'s rilparencel-branded therapy is "to demonstrate the therapy's potential to preserve kidney ...
An elderly male lion at the Akron Zoo, described as a “staple icon” has been diagnosed with chronic kidney disease, the zoo announced over the weekend.
AstraZeneca's baxdrostat demonstrated significant blood pressure reduction in a late-stage trial for treatment-resistant ...
AstraZeneca said on Monday its experimental drug baxdrostat significantly lowered blood pressure in a late-stage trial of ...
SUMMIT COUNTY, Ohio (WOIO) -The elderly male lion at the Akron Zoo has been diagnosed with chronic kidney disease and is under treatment, according to Akron Zoo officials. Tamarr, who will turn 20 on ...
Berlin: Bayer has received approval from the U.S. Food and Drug Administration (FDA) for finerenone (Kerendia), a ...
Tamarr is now off exhibit and is in "stable" condition under the observation of the zoo's animal care and veterinary teams.
Real-world data suggest that finerenone is both effective and safe for patients with non-diabetic chronic kidney disease (CKD), although larger prospective studies are necessary to validate ...